Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5951
    +0.0014 (+0.23%)
     
  • NZD/EUR

    0.5550
    +0.0005 (+0.08%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.96
    +0.15 (+0.18%)
     
  • GOLD

    2,332.70
    -5.70 (-0.24%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,090.65
    +50.27 (+0.63%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,044.31
    -44.39 (-0.25%)
     
  • Hang Seng

    17,301.37
    +100.10 (+0.58%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • NZD/JPY

    92.5630
    +0.4480 (+0.49%)
     

Better Coronavirus Stock: AstraZeneca or Moderna?

Better Coronavirus Stock: AstraZeneca or Moderna?

Moderna has been a much bigger winner than AstraZeneca year to date. Probably the best argument for buying AstraZeneca instead of Moderna is that it's less risky. AstraZeneca, on the other hand, can more readily absorb any setbacks because of its diversified portfolio.